The impact of treatment package time on locoregional control for HPV+ oropharyngeal squamous cell carcinoma treated with surgery and postoperative (chemo)radiation

For patients with head and neck squamous cell carcinoma (SCC) undergoing surgery followed by postoperative radiotherapy (PORT), time from surgery to completion of adjuvant therapy, “package time” impacts locoregional control (LRC). However, the significance of package time in HPV+ oropharyngeal SCC (OPSCC) is unknown.

[1]  A. Ho,et al.  Quantitative survival impact of composite treatment delays in head and neck cancer , 2018, Cancer.

[2]  C. von Buchwald,et al.  Impact of Time to Treatment Initiation in Patients with Human Papillomavirus-positive and -negative Oropharyngeal Squamous Cell Carcinoma. , 2018, Clinical oncology (Royal College of Radiologists (Great Britain)).

[3]  T. Day,et al.  Effect of time to initiation of postoperative radiation therapy on survival in surgically managed head and neck cancer , 2017, Cancer.

[4]  F. Faraji,et al.  The role of human papillomavirus on the prognosis and treatment of oropharyngeal carcinoma , 2017, Cancer and Metastasis Reviews.

[5]  R. Mehra,et al.  The Impact of Radiation Treatment Time on Survival in Patients With Head and Neck Cancer. , 2016, International journal of radiation oncology, biology, physics.

[6]  G. Weinstein,et al.  HPV‐related oropharyngeal cancer: Risk factors for treatment failure in patients managed with primary transoral robotic surgery , 2016, Head & neck.

[7]  E. Sturgis,et al.  Epidemiology of HPV-associated oropharyngeal cancer. , 2014, Oral oncology.

[8]  G. Weinstein,et al.  Transoral robotic surgery alone for oropharyngeal cancer: an analysis of local control. , 2012, Archives of otolaryngology--head & neck surgery.

[9]  L. Specht,et al.  The influence of HPV-associated p16-expression on accelerated fractionated radiotherapy in head and neck cancer: evaluation of the randomised DAHANCA 6&7 trial. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[10]  K. Ang,et al.  Human papillomavirus and survival of patients with oropharyngeal cancer. , 2010, The New England journal of medicine.

[11]  Jens Overgaard,et al.  Effect of HPV-associated p16INK4A expression on response to radiotherapy and survival in squamous cell carcinoma of the head and neck. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[12]  M. van Glabbeke,et al.  Defining risk levels in locally advanced head and neck cancers: A comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501) , 2005, Head & neck.

[13]  Lisa Barbera,et al.  Does delay in starting treatment affect the outcomes of radiotherapy? A systematic review. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[14]  R. Weber,et al.  Importance of the treatment package time in surgery and postoperative radiation therapy for squamous carcinoma of the head and neck , 2002, Head and Neck.

[15]  A. Garden,et al.  Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer , 2001 .

[16]  B. Vikram,et al.  Importance of the time interval between surgery and postoperative radiation therapy in the combined management of head & neck cancer. , 1979, International journal of radiation oncology, biology, physics.